Glenmede Trust Company »

Nektar Therapeutics shares owned by Glenmede Trust Company

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Glenmede Trust Company from 13F filings

Historical chart of Glenmede Trust Company investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Glenmede Trust Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Glenmede Trust Company

Quarter filed Position value Share count Share price at filing
2026-03-31 $998k 14k 71.95
2025-12-31 $363k 8.6k 42.28

More positions owned by Glenmede Trust Company

Vanguard Index Fds S&p 500 Etf S&p 500 Etf Shs (VOO)
Apple (AAPL)
Ishares S & P Smallcap 600 Core S&p Scp Etf (IJR)
Microsoft Corporation (MSFT)
Call On Spy 12/18/26 @ 680 Tr Unit Call Option (SPY)
Alphabet Inc Cap Stk Cl A Cap Stk Cl A (GOOGL)
Johnson & Johnson (JNJ)
JPMorgan Chase & Co. (JPM)
Ishares Russell 2500 Etf Rusel 2500 Etf (SMMD)
Putnam Focused Large Cap Value Etf Focused Lar Cap (PVAL)
Alphabet Inc Cap Stk Cl C Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Vanguard Index Fds Small Cap Etf Small Cp Etf (VB)

View all positions for Glenmede Trust Company

Top funds holding Nektar Therapeutics

FMR
BVF
Two Seas Capital
Vanguard Capital Management
Vanguard Group
Two Sigma Investments
Susquehanna International
Prosight Management
BlackRock
Citadel Advisors
Morgan Stanley
Armistice Capital
Invesco
Sofinnova Ventures
Woodline Partners

View all funds holding Nektar Therapeutics